Surfactin inducing mitochondria-dependent ROS to activate MAPKs, NF-κB and inflammasomes in macrophages for adjuvant activity

Abstract

Surfactin, a natural lipopeptide, can be used both as parenteral and non-parenteral adjuvant for eliciting immune response. However, the mechanisms that confer its adjuvant properties have not been fully explored. By staining with NHS-Rhodamine B labeled surfactin and Mito-Tracker Green, we found surfactin could penetrate into macrophages to bind with mitochondria, following induce ROS that could be inhibited by mitochondria-dependent ROS inhibitor. ROS enhanced p38 MAPK and JNK expression, as well their phorsphorylation, following activated NF-κB nuclear translocation in macrophages that was obviously inhibited by mitochondria-dependent ROS inhibitor. However, inhibition of ROS production only weakened p38 MAPK and JNK expression, but not their phosphorylation in macrophages. As a result, surfaction could activate NF-κB to release TNF-α by the mitochondria-dependent ROS signalling pathway. ROS also induced macrophages apoptosis to release endogenous danger signals, following activated inflammasomes of NLRP1, NLRP3, IPAF and AIM2 in vitro and only NLRP1 in vivo, as well caspase-1 and IL-1 in macrophages, which were significantly inhibited by pre-treatment with ROS inhibitors. Collectively, surfactin as a kind of non-pathogen-associated molecular patterns, modulates host innate immunity by multiple signalling pathways, including induction of mitochondria-dependent ROS, activating MAPKs and NF-κB, and inducing cell apoptosis to realease endogenous danger signals for activation of inflammasomes.

Ketogenic Diet Ameliorates Cardiac Dysfunction via Balancing Mitochondrial Dynamics and Inhibiting Apoptosis in Type 2 Diabetic Mice

“…In addition to supplying energy, mitochondria have been recognized as a main source of ROS in the myocardium. Mitochondrial dysfunction results in excessive ROS generation [44]. In this study, we found increased ROS generation in the myocardium accompanied by increased MDA production and decreased MnSOD activity in diabetic mice.…”

The MC4 receptor agonist RO27‐3225 inhibits NLRP1‐dependent neuronal pyroptosis via the ASK1/JNK/p38 MAPK pathway in a mouse model of intracerebral haemorrhage

“…MAPKs, consisting of ERK1/2, c‐JNK, and p38 MAPK, are involved in directing cellular responses to various stimuli, thus regulating cell proliferation and differentiation, stress responses, immune function, and cell death (Cai et al, ; Gan, Gao, Zhao, & Qi, ). The apoptosis signalling‐regulating kinase 1 (ASK1) is known as a MAP3K that activates the JNK/p38 MAPK signalling pathway (Barros‐Minones et al, ; Tobiume et al, ).…”

Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice

“…It is well‐known that the activation of inflammasomes can affect adaptive immune responses . WH1fungin, one of SF family members, activated mitogen‐activated protein kinases, nuclear factor‐κB, and inflammasomes in macrophages in vitro . It was also reported that PMB activated NLRP3 inflammasomes in dendritic cells in vitro .…”